Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Infectious Diseases and Their Occurrence

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...

Vaccinations

Vaccinations

Influenza

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

Lyme disease in Poland in 2023.

Przeglad epidemiologiczny·2026

Same authorSame journal

Pertussis in Poland in 2023.

Przeglad epidemiologiczny·2026

Same author

Public spending on immunisation in Poland.

Frontiers in public health·2025

Same author

Chickenpox in Poland in 2023.

Przeglad epidemiologiczny·2025

Same author

Mumps in Poland in 2023.

Przeglad epidemiologiczny·2025

Same author

Measles in Poland: 2022-2023.

Przeglad epidemiologiczny·2025

Search research articles

Related Experiment Video

Updated: May 7, 2026

Merkel Cell Polyomavirus Infection and Detection

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

Mumps in Poland in 2011.

Małgorzata Lipke¹, Iwona Paradowska-Stankiewicz

¹Department of Epidemiology, National Institute of Public Health- National Institute of Hygiene, Warsaw, Poland. mgluchowska@pzh.gov.pl

Przeglad Epidemiologiczny

|September 18, 2013

Summary

Poland

Area of Science:

Epidemiology
Public Health
Vaccinology

Background:

Mumps cases declined in Poland by 2011, continuing a trend from previous years.
This decline is attributed to the mandatory mumps vaccination program established in 2003, utilizing a two-dose MMR vaccine schedule.
The MMR vaccine protects against mumps, measles, and rubella.

Purpose of the Study:

To evaluate the epidemiological status of mumps in Poland during 2011.
To compare the 2011 mumps incidence with data from preceding years.

Main Methods:

Analysis of infectious disease data from the "Infectious diseases and poisoning in Poland in 2011" bulletin.
Review of the "Preventative immunisation in Poland in 2011" bulletin.
Utilized case definitions for infectious diseases (2009-2011) and the 2011 Preventative Vaccination Program.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Related Experiment Videos

Last Updated: May 7, 2026

Merkel Cell Polyomavirus Infection and Detection

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Main Results:

A total of 2585 mumps cases were reported in Poland in 2011.
The incidence rate decreased to 6.7/100,000 from 7.2/100,000 in 2010, and was nearly half the 2005-2009 median.
Children aged 5-9 years had the highest incidence rate (52.0/100,000); incidence was higher in men (7.9/100,000) than women (5.6/100,000).
24 individuals were hospitalized due to mumps in 2011.

Conclusions:

Consistent adherence to the national vaccination schedule has led to a substantial reduction in reported mumps cases.
The mumps vaccination program is effective in controlling the disease's spread.